CD24 and neoplasm: In addition, they obtained the enhancement of anti-tumor immunity by macrophages when monoclonal antibodies were used to block of CD24/Siglec-10 anti-phagocytic signal which strongly supports the Siglec-10 inhibition activity against phagocytosis.